Clinical Trials Browser

Completed × Has results × vinflunine × Clear all

Locally Advanced or Metastatic Unresectable Urothelial Cancer

NCT03474107 2026-01-09

A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

Phase 3 Completed

608 enrolled 22 charts 1 FDA

Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms

NCT01095003 2022-04-28

Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer

Phase 3 Completed

770 enrolled 13 charts

Breast

Breast Neoplasms

NCT00545766 2021-12-16

Vinflunine in Hormone Refractory Prostate Cancer (HRPC)

Phase 2 Completed

41 enrolled 11 charts

Genitourinary

Prostatic Neoplasms

NCT02256436 2021-09-20

MK-3475-045

Phase 3 Completed

542 enrolled 31 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT01091168 2019-09-16

Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer

Phase 3 Completed

594 enrolled 11 charts

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02302807 2019-08-01

A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]

Phase 3 Completed

931 enrolled 21 charts

Genitourinary

Urinary Bladder Neoplasms

NCT01953003 2019-05-02

Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Phase 3 Completed

112 enrolled 11 charts

Breast

Breast Neoplasms

NCT02347332 2019-03-05

Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer

Phase 3 Completed

459 enrolled 13 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Recurrence

NCT00284180 2013-08-09

Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer

Phase 2 Completed

32 enrolled 6 charts

Breast

Breast Neoplasms

NCT00284154 2013-03-13

Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer

Phase 2 Completed

51 enrolled 10 charts

Thoracic

Lung Neoplasms, Recurrence, Carcinoma, Small Cell

Clinical Trials

TROPiCS-04

A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer

Vinflunine in Hormone Refractory Prostate Cancer (HRPC)

MK-3475-045

Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer

A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]

Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer

Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer

Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer